Potentiation by thyroxine of interferon-γ-induced HLA-DR expression is protein kinase A- and C-dependent

Journal of Interferon and Cytokine Research

Volumn 16, Issue 1, 1996, Pages 17-24

  Lin, Hung Yun ^a   Thacore, Harshad R ^b   Davis, Faith B ^a   Martino, Leon J ^a   Davis, Paul J ^a,c  

^a ALBANY MEDICAL COLLEGE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c STRATTON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 8 BROMO CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; HLA DR ANTIGEN; KT 5720; LEVOTHYROXINE; LIOTHYRONINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MIDOSTAURIN; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR; RECOMBINANT GAMMA INTERFERON; STAUROSPORINE;

ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; HELA CELL; HLA SYSTEM; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0030071747     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1996.16.17     Document Type: Article

References (46)

1. SEN, G.C., and LENGYEL, P. (1992). The interferon system. A bird's eye view of its biochemistry. J. Biol. Chem. 267, 5017-5020.
2. BENOIST, C., and MATHIS, D. (1990). Regulation of major histocompatibility complex class II genes: X, Y and other letters of the alphabet. Annu. Rev. Immunol. 8, 681-715.
3. LING, P.D., WARREN, M.K., and VOGEL, S.N. (1985). Antagonistic effect of interferon-β on the interferon-γ-induced expression of Ia antigen in murine macrophages. J. Immunol. 135, 1857-1863.
4. INABA, K., KITAURA, M., KATO, T., WATANADE, Y., and MURAMAKSU, S. (1986). Contrasting effect of α/β- and γ-interferons on expression of macrophage Ia antigen. J. Exp. Med. 163, 1030-1035.
5. 2+-calmodulin complex are involved in interferon-γ-induced expression of HLA class II molecules on HL-60 cells. Proc. Natl. Acad. Sci. USA 85, 3120-3124.
6. FAN, X-.D., GOLDBERG, M., and BLOOM, B.R. (1988). Interferon-γ-induced transcriptional activation is mediated by protein kinase C. Proc. Natl. Acad. Sci. USA 85, 5122-5125.
7. BESTA, P.V., MOORE, T.L., YOKOTA, S., and TING, J.P.-Y. (1989). A β-adrenergic agonist modulates DRa gene transcription via enhanced cAMP levels in a glioblastoma multiforme line. J. Immunol. 142, 2895-2901.
8. CELADA, A., and MAKI, R.A. (1991). IFN-γ induces the expression of the genes for MHC class III-Aβ and tumor necrosis factor through a protein kinase C-independent pathway. J. Immunol. 146, 114-120.
9. TODD, I., PUJOL-BORRELL, R., ABDUL-KARIN, B.A.S., HAMMOND, L.J., FELDMANN, M., and BOTTAZZO, G.F. (1987). HLA-D subregion expression by thyroid epithelium in autoimmune thyroid diseases and induced in vitro. Clin. Exp. Immunol. 69, 532-542.
10. RAYNER, D.C., LYDYARD, P.M., DEASSIS-PAIVA, H.J., BIDEY, S., VAN DER MEIDE, P., VAREY, A.-M., and COOKE A. (1987). Interferon-mediated enhancement of thyroid major histocompatibility complex antigen expression. A flow cytometric analysis. Scand. J. Immunol. 25, 621-628.
11. BUSCEMA, M., TODD, I., DEUSS, U., HAMMOND, L., MIRAKIAN, R., PUJOL-BORRELL, R., and BOTTAZZO, G.F. (1989). Influence of tumor necrosis factor-α on the modulation by interferon-γ of HLA class II molecules in human thyroid cells and its effect on interferon-γ binding. J. Clin. Endocrinol. Metab. 69, 433-439.
12. SKJODT, H., HUGHES, D.E., DOBSON, P.RM., and RUSSELL, R.G.G. (1990). Constitutive and inducible expression of HLA class II determinants by human osteoblast-like cells in vitro. J. Clin. Invest. 85, 1421-1426.
13. LIN, H.Y., DAVIS, F.B., MARTINO, L.J., HOGG, M.G., THACORE, H.R., and DAVIS, P.J. (1994). Thyroid hormone potentiates rHuIFN-γ-induced HLA-DR expression in HeLa cells by a protein kinase-dependent mechanism. Thyroid 4(Suppl.), S-79.
14. HANAFUSA, T., CHIOVATO L., DONIACH, D., PUJOL-BORRELL, R., RUSSELL, R.C.G., and BOTTAZZO, G.F. (1983). Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet 2, 1111-1115.
15. MATSUNAGA, M., EGUCHI, K., FUKUDA, T., KURATA, A., TEZUKA, H., SHIMOMURA, C., OTSUBO, T., ISHIKAWA, N., ITO, K., and NAGATAKI, S. (1986). Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease. J. Clin. Endocrinol. Metab. 62, 723-734.
16. LIN, H.Y., THACORE, H.R., DAVIS, P.J., and DAVIS, F.B. (1994). Thyroid hormone potentiates the antiviral action of interferon-γ in cultured human cells. J. Clin. Endocrinol. Metab. 79, 62-65.
17. SAMUELS, H.H., STANLEY, F., and CASANOVA, J. (1979). Depletion of L-3,5,3′-triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology 105, 80-85.
18. 3 rat pituitary cells. Endocrinology 131, 1883-1888.
19. GALI, R.R., PUGAZHENTHI, S., and KHANDELWAL, R.L. (1993). Reciprocal effects of the protein kinase C inhibitors staurosporine and H-7 on the regulation of glycogen synthase and phosphorylase in the primary culture of hepatocytes. Metabolism 42, 1475-1480.
20. TOPLISS, D.J., SCHOLZ, G.H., and KOLLINIATIS, E. (1993). Influence of calmodulin antagonists and calcium channel blockers on triiodothyronine uptake by rat hepatoma and myoblast cell lines. Metabolism 42, 376-380.
21. KASE, H., IWAHASHI, K., NAKANISHI, S., MATSUDA, Y., YAMADA, K., TAKAHASHI, M., MURAKATA, C., SATO, A., and KANEKO, M.. (1987). K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem. Biophys. Res. Commun. 142, 436-440.
22. AMON, U., VON STEBUT, E., SUBRAMANIAN, N., and WOLFF, H.H. (1993). CGP41251, a novel protein kinase inhibitor with in vitro selectivity for protein kinase C, strongly inhibits immunological activation of human skin mast cells and human basophils. Pharmacology 47, 200-208.
23. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
24. LAEMMLI, U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacterial phage T4. Nature 227, 680-685.
25. OLSON, E.N., BURGESS, R., and STAUDINGER, J. (1993). Protein kinase C as a transducer of nuclear signals. Cell Growth Differ. 4, 699-705.
26. 2. J. Clin. Invest. 93, 571-577.
27. EXTON, J.H. (1990). Signaling through phosphatidylcholine breakdown. J. Biol. Chem. 265, 1-4.
28. LAWRENCE, W.D., SCHOENL, M., and DAVIS, P.J. (1989). Stimulation in vitro of rabbit erythrocyte cytosol phospholipid-dependent protein kinase activity. A novel action of thyroid hormone. J. Biol. Chem. 264, 4766-4768.
29. CAMBIER, J.C., NEWELL, M.K., JUSTEMENT, L.B., McGUIRE, J.C., LEACH, K.L., and CHEN, Z.Z. (1987). Ia binding ligands and cAMP stimulate nuclear translocation of PKC in B lymphocytes. Nature 327, 629-632.
30. GOLDBERG, Y., GLINEUR, C., GESQUIERE, J.-C., RICOUART, A., SAP, J., VENNSTROM, B., and GHYSDAEL, J. (1988). Activation of protein kinase C or cAMP-dependent protein kinase increases phosphorylation of the c-erbA-encoded thyroid hormone receptor and of the v-erbA-encoded protein. EMBO J. 7, 2425-2433.
31. DANNER, L.A., WEIGEL, N.L., MAXWELL, B.L., SCHRADER, W.T., and O'MALLEY, B.W. (1990). Regulation of progesterone receptor-mediated transcription by phosphorylation. Science 250, 1740-1743.
32. SCHINDLER, C., SHUAI, K., PREZIOSO, V.R., and DARNELL, J.E., Jr. (1992). Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257, 809-813.
33. LUSCHNER, B., CHRISTENSON, E., LITCHFIELD, D.W., KREBS, E.G., and EISENMAN, R.N. (1990). Myb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activation. Nature 344, 517-522.
34. JONES, K.E., BRUBAKER, J.H., and CHIN, W.W. (1994). Evidence that phosphorylation events participate in thyroid hormone action. Endocrinology 134, 543-548.
35. LAHAT, N., SOBEL, E., and KRAIEM, Z. (1993). Control of HLA-DR antigen expression by γ-interferon: separate signal transduction mechanisms in malignant and nonmalignant human thyroid cells. Cancer Res. 53, 3943-3947.
36. RYU, K., KOIDE, Y., YAMASHITA, Y., and YOSHIDA, T.O. (1993). Inhibition of tyrosine phosphorylation prevents IFN-γ induced HLA-DR molecule expression. J. Immunol. 150, 1253-1262.
37. NEZU, N., RYU, K., KOIDE, Y., and YOSHIDA, T.O. (1990). Regulation of HLA class II molecule expression by IFN-γ. The signal transduction mechanism in glioblastoma cell lines. J. Immunol. 145, 3126-3135.
38. MATTILA, P., HAYRY, P., and RENKONEN, R. (1989). Protein kinase C is crucial in signal transduction during IFN-γ induction in endothelial cells. FEBS Lett. 250, 362-366.
39. BLANAR, M.A., BOETTGER, E.C., and FLAVELL, R.A. (1988). Transcriptional activation of HLA-DRα by interferon-γ requires a trans-acting protein. Proc. Natl. Acad. Sci. USA 85, 4672-4676.
40. AMALDI, I., REITH, W., BERTE, C., and MACH, B. (1989). Induction of HLA class II genes by IFN-γ is transcriptional and requires a trans-acting protein. J. Immunol. 142, 999-1004.
41. CELADA, A., KLEMSZ, M.J., and MAKI, R.A. (1989). Interferon-γ activates multiple pathways to regulate the expression of the genes for major histocompatibility class II I-Aβ, tumor necrosis factor and complement component C3 in mouse macrophages. Eur. J. Immunol. 19, 1103-1109.
42. SHUAI, K., STARK, G.R., KERR, I.M., and DARNELL, J.E., Jr. (1993). A signal phosphotyrosine residue of Stat91 required for gene activation by interferon-γ. Science 261, 1744-1746.
43. STEIMLE, V., SIEGRIST, C.-A., MOTTET, A., LISOWSKA-GROSPIERRE, B., and MACH, B. (1994). Regulation of MHC class II expression by IFN-γ mediated by the transactivator gene CIITA. Science 265, 106-109.
44. RÜEGG, U.T., and BURGESS, G.M. (1989). Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases. Trends Pharmacol. Sci. 10, 218-220.
45. SOBEL, A. (1991). Stathmin: a relay phosphoprotein for multiple signal transduction? Trends Biochem. Sci. 16, 301-305.
46. DAVIS, P.J., THACORE, H.R., LIN, H.-Y., DAVIS, F.B., and HOGAN, J.E. (1992). Potentiation by thyroid hormone of antiviral action of interferon-gamma: thyroid hormone and interferon-gamma stimulate phosphorylation of the p19 signal transduction complex in human fibroblasts. Thyroid 2(Suppl.), 144.